AVRAVRHealthcare · Medical Devices

AVR Stock Forecast: Anteris Technologies Global Corp. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$4.99
−1.96% on the day

The median 12-month analyst price target for Anteris Technologies Global Corp. is $15. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 25 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$486.5M
Ticker Nerd rank
25/ 100
Median analyst target
$15
Analysts covering
5
Revenue$1.0M+63.3% y/y
Operating income−$31.0M
Net income−$28.8M
Free cash flow−$21.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−7.9%
1M
−20.7%
YTD
0.0%
1Y
+47.6%
From 52W high
−52.8%
From 52W low
+47.6%
$3
$11
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Anteris Technologies Global Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
25/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
77
Revisions
72
Momentum
49
Quality
24
Accruals
22
Volatility
21
Value
12
Issuance
10

Growth (77): Sales and profits are climbing, and climbing faster than before.

Issuance (10): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

AVR stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AVR, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15Jan 26Apr 26Jul 26Oct 26AVRHigh $16Median $15Low $9

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
4
Buy
1
Hold
0
Sell
$9
Low
$15
Median
$16
High
Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 Nov 2026BarclaysMaintainsEqual-Weight$10 → $9.00
14 Oct 2026Cantor FitzgeraldReiteratesOverweight$15
7 Oct 2026BarclaysInitiatesEqual-Weight$10
14 Aug 2026Cantor FitzgeraldReiteratesOverweight$15
15 May 2026BarclaysMaintainsOverweight$17 → $18
27 Mar 2026Cantor FitzgeraldReiteratesOverweight—
12 Mar 2026Cantor FitzgeraldAssumesOverweight$15
11 Mar 2026Wells FargoInitiatesOverweight—
8 Jan 2025Lake StreetInitiatesBuy—
7 Jan 2025BarclaysInitiatesOverweight—
7 Jan 2025Cantor FitzgeraldInitiatesOverweight—
7 Jan 2025TD CowenInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for AVR.

Market Radar

This page is one stock. Monday covers all of them.

AVR appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

AVR vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Anteris Technologies Global Corp. returned +47.6% against +6.9% for the S&P 500, dividends included.

AVR vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200250300Jan 26Apr 26Jul 26Oct 26AVRS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

AVR analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
2
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
208.6×

Cheaper than 2% of US stocks

Price / book
2.1×

Cheaper than 41% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
76.9%

Higher than 89% of US stocks

Operating margin
—
Net margin
—
Returns & dividend
Return on equity
−93.3%

Higher than 14% of US stocks

Return on assets
−50.5%

Higher than 8% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Anteris Technologies Global Corp. has a market value of $486.5M and an enterprise value of $270.6M.

  • Revenue in the twelve months to 30 June 2026: $2.2M. The latest quarter grew 63.3% year on year.

  • Net income over the same four quarters: −$102.9M, a −4590.0% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$88.3M.

  • Shares outstanding: 97.4M.

  • Anteris Technologies Global Corp. employs 174 people — $13K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 22 Nov 2026

Data provided by Twelve Data

Peers

AVR and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
AVRAnteris Technologies Global Corp.$486.5M25
RCELAVITA Medical, Inc.$483.1M85
PACBPacific Biosciences of California, Inc.$492.3M68
SGHTSight Sciences, Inc.$549.8M85
SIShoulder Innovations, Inc.$419.5M63
SENSSenseonics Holdings, Inc.$418.7M33
QDELQuidelOrtho Corp.$567.3M48

Take a look at AVR’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Anteris Technologies Global Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about AVR

What is the AVR stock price forecast for 2026-2027?

The median 12-month analyst price target for Anteris Technologies Global Corp. is $15, with estimates ranging from $9 to $16. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AVR stock a buy right now?

Of the 5 analysts covering Anteris Technologies Global Corp., 4 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Anteris Technologies Global Corp. 25 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AVR?

As at 21 Nov 2026, Anteris Technologies Global Corp. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (77 of 100).

Will AVR stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts is $15, and Ticker Nerd's factor model ranks Anteris Technologies Global Corp. 25 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AVR stock forecast for 2030?

No analyst covering Anteris Technologies Global Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AVR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $9 to $16 over the next 12 months.

How has AVR stock performed over the past year?

Anteris Technologies Global Corp. returned +47.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Anteris Technologies Global Corp. do?

Anteris Technologies Global Corp. is a structural heart company focused on designing, developing, and commercializing minimally invasive medical devices for heart valve disease. Its portfolio centers on transcatheter aortic valve replacement systems and related technologies intended to restore healthy heart function in patients with aortic stenosis.

Company

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a structural heart company focused on designing, developing, and commercializing minimally invasive medical devices for heart valve disease. Its portfolio centers on transcatheter aortic valve replacement systems and related technologies intended to restore healthy heart function in patients with aortic stenosis. The company also works on complementary structural heart solutions, including specialized tissue materials and delivery systems that support precise implantation and procedural performance. Anteris Technologies Global Corp. serves the cardiovascular care market, where its products are used by physicians and cardiac specialists in treatment settings that require advanced device-based interventions. With operations spanning multiple regions, the company plays a role in the broader medical technology sector by addressing the needs of patients and clinicians seeking catheter-based alternatives for heart valve repair and replacement.

CEO Mr. Wayne Geoffrey Paterson · 174 employees · Australia · https://anteristech.com